I must admit, I used to think why is CB spending on buying...

I must admit, I used to think why is CB spending on buying companies that is why the SP is too low but I have looked beyond and see how these companies are tied up to being like a one stop shop. They can bundle items together. We don't see these presentations but we can see already when he discusses about illucix and 591 that they have this timeline on what their plans are until end stage. Other companies like Dedicaid and Lightpoint are supplementary to existing diagnostics/therapy. Even QSAM is for bone cancer so will it complement 591??

They mentioned about ARTMS having stockpile of a Ultra pure metals and advance isotope production. This will help with their production capacity as products such as illuccix becomes the standard of diagnosis. It is even looking even that radio therapy could be the standard but we need to wait and see the trial result but phase 2 is impressive.

Good luck all and maybe in a few years, we have a complete Theranostic package.